Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
University Hospitals Brain Health & Memory Center is now treating patients with KISUNLA™ (donanemab), a Food and Drug ...
Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.
In today’s fast-paced world, maintaining optimal cognitive function is essential. Many people struggle with brain fog, ...
The FDA is set to consider approval of an alternative to ... which act directly on the brain and can lead to addiction. The drug has been billed as nonaddictive by Vertex, though some experts ...
Cork medtech company Cergenx has secured the support of US regulators for a device that allows maternity hospital staff to detect brain injury ... States’s Food and Drug Administration (FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback